Warfarin Increases Stroke Risk in Atrial Fibrillation Patients

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A study published in the European Heart Journal finds that atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy. Data on stroke incidence in patients newly diagnosed with atrial fibrillation was analyzed and each case of stroke was randomly matched with 10 controls. Stroke risk was significantly higher among patients who had begun taking warfarin within 30 days when compared with patients who had not used any antithrombotic therapy for at least 1 year. Patients taking warfarin had a lower risk for stroke when they had been taking the drug longer than 1 month.

To read the full article on HCPLive.com, click here.
Related Articles
Teva has launched a generic version of aspirin and extended-release dipyridamole (Aggrenox) capsules in the United States.
A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin.
Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.
Here are new drugs for 2015 pharmacists can expect to handle.
Latest Issues
$auto_registration$